Recombinant Rat S100A8 Protein，His

S100A8, a member of the S100 protein family, is a calcium-binding protein predominantly expressed in myeloid cells, playing a pivotal role in various physiological and pathological processes. Understanding S100A8 has garnered significant interest due to its involvement in inflammation, cancer progression, and autoimmune diseases. The protein functions by influencing the immune response, acting as a damage-associated molecular pattern (DAMP) that promotes inflammatory signaling pathways through receptor interactions, notably with TLR4 and RAGE. Elevated levels of S100A8 have been linked to various inflammatory conditions, such as rheumatoid arthritis and inflammatory bowel disease, highlighting its potential as a biomarker and therapeutic target. Additionally, research has indicated that S100A8 may contribute to tumor microenvironment modifications, promoting cancer cell proliferation and metastasis. The recombinant protein has been utilized in numerous studies to dissect its function, binding properties, and therapeutic implications. As researchers continue to explore the multifaceted roles of S100A8, the production and study of recombinant S100A8 proteins enhance our understanding of its biological functions and the mechanisms underlying its involvement in disease, paving the way for novel therapeutic strategies to modulate its activity in relevant pathologies.